Viewing nowHygroton Tablet 25 mg (Chlorthalidone)
Chlorthalidone 25mg
Tablet · Prescription medication
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 200302309 · Notified 2003.09.01 · Insurance code 645302230
Treatment of hypertension, mild to moderate chronic stable heart failure, and edema
This medication helps control various forms of hypertension, such as essential hypertension, renal hypertension, and systolic hypertension. It is also used in patients with mild to moderate chronic stable heart failure to improve heart function. Additionally, it is effective in reducing edema caused by cirrhosis or kidney disease. This medication is used for blood pressure control, heart failure treatment, and edema improvement.
The dose of this drug should be established by determining the minimum effective dose for each patient; this is particularly important in elderly patients. This drug is administered orally, and a single dose in the morning is recommended. Hypertension: The recommended initial dose is 25 mg per day. Most patients achieve the maximum effect with a 25 mg dose; however, if this dose is considered insufficient, it may be increased to 50 mg per day. If further blood pressure reduction is needed, this drug may be used in combination with other therapies. Chronic stable heart failure: The recommended initial dose is 25 ~ 50 mg per day. In severe cases, the dose may be increased to 100 ~ 200 mg per day. The usual maintenance dose is the minimum effective dose, for example, 25 ~ 50 mg per day, administered daily or every other day. If a satisfactory therapeutic effect is not achieved, digitalis and/or an ACE inhibitor may be used concomitantly. Edema: Administer the minimum effective dose confirmed by measurement for a limited period only. Do not exceed 50 mg per day. Elderly patients and patients with renal impairment: Use the minimum effective dose in patients with mild renal impairment and in elderly patients. Compared with healthy adults, absorption of this drug is equivalent in elderly patients, but elimination is slower; therefore, the recommended dose should be reduced. Elderly patients receiving this drug require careful monitoring. This drug and thiazide diuretics lose their diuretic effect when creatinine clearance is 30 mL/min or less.
Administer the minimum effective dose. For example, the initial dose is 0.5 ~ 1 mg/kg/48 hr, and the maximum dose is 1.7 mg/kg/48 hr.
This medication should be used with caution in patients with impaired liver function or progressive liver disease as it may cause hepatic coma. In patients with severe kidney disease, this medication may cause azotemia and there is a risk of accumulation in the body, so it should be administered carefully. Patients with anuria or severe liver failure or renal failure should not use this medication. Patients with allergies to this medication, its components, or similar drugs should not be administered this medication. Use should be avoided in patients with hypokalemia, hyponatremia, hypercalcemia, symptomatic hyperuricemia, and it is also safest for pregnant or nursing women not to use it. This medication is contraindicated in untreated patients with Addison’s disease, patients undergoing lithium treatment, and those taking certain heart-related medications. Patients with lactose intolerance or specific genetic disorders should not take this medication. Patients with impaired liver function, arteriosclerosis, a family history of gout or diabetes, or those with diarrhea or vomiting should use this medication with caution. This medication may cause electrolyte imbalances, so particular care should be taken with hypokalemia and hyponatremia, and potassium supplements may be used if necessary. Metabolic anomalies such as hyperglycemia, increased blood lipid levels, and exacerbation of gout may also occur, so regular testing is needed. Dizziness or orthostatic hypotension may occur while taking this medication, so caution should be exercised while driving or operating machinery. This medication may interact with other drugs, so it is essential to inform about any medications being taken, particularly when used with antihypertensives, antidiabetics, lithium, or NSAIDs. If pregnant or breastfeeding, the use should be avoided as it may affect the fetus and newborn, and it is recommended to discontinue breastfeeding while using this medication. Elderly patients or infants are at higher risk for electrolyte imbalances, so it is advisable to start with a small dose and closely monitor their condition. In cases of overdose, symptoms such as low blood pressure, electrolyte abnormalities, and consciousness disturbances may occur, and immediate medical attention should be sought. This medication should be stored in a closed container to avoid exposure to air or moisture, and it should be kept in a cool place away from direct sunlight and out of reach of children.
Aplastic anemia, necrotizing vasculitis, pulmonary edema, pancreatitis, agranulocytosis, acute renal failure, toxic epidermal necrolysis (Lyell's syndrome), hypokalemia, hyperuricemia, increased blood lipids, hyponatremia, hypomagnesemia, hyperglycemia, gout, hypercalcemia, diabetes, exacerbation of diabetic metabolic state, hypochloremic alkalosis, urticaria, skin erythema, photosensitivity reactions, intrahepatic cholestasis of bile, jaundice, orthostatic hypotension, cardiac arrhythmias, palpitations, dizziness, paresthesia, headache, depression, heaviness, loss of appetite, gastrointestinal distress, nausea, vomiting, abdominal pain, constipation, diarrhea, thrombocytopenia, leukopenia, agranulosis, eosinophilia, purpura, visual disturbances, yellowing of the skin, erectile dysfunction, pulmonary edema, allergic enteritis, fatigue, weakness, hypotension, tachycardia, hypovolemic shock, consciousness disorders, coma, muscle elasticity, muscle cramps, fatigue, drowsiness, confusion, thirst, polyuria, blood concentration, oliguria, anuria, venous thrombosis, drowsiness, hypovolemia, arrhythmia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture. It is best to maintain a storage temperature between 1 degree Celsius and 30 degrees Celsius at room temperature.
Pale pink round tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.